23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The SLC25A47 locus controls gluconeogenesis and energy expenditure

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          Given the impenetrable nature of the mitochondrial inner-membrane, most of the known metabolite carrier proteins, including SLC25A family members, are ubiquitously expressed in mammalian tissues. One exception is SLC25A47, which is selectively expressed in the liver. The present study showed that depletion of SLC25A47 reduced mitochondrial pyruvate flux and hepatic gluconeogenesis under a fasted state, while activating energy expenditure. The present work offers a liver-specific target through which we can restrict hepatic gluconeogenesis, which is often in excess under hyperglycemic and diabetic conditions.

          Abstract

          Mitochondria provide essential metabolites and adenosine triphosphate (ATP) for the regulation of energy homeostasis. For instance, liver mitochondria are a vital source of gluconeogenic precursors under a fasted state. However, the regulatory mechanisms at the level of mitochondrial membrane transport are not fully understood. Here, we report that a liver-specific mitochondrial inner-membrane carrier SLC25A47 is required for hepatic gluconeogenesis and energy homeostasis. Genome-wide association studies found significant associations between  SLC25A47 and fasting glucose, HbA1c, and cholesterol levels in humans. In mice, we demonstrated that liver-specific depletion of SLC25A47 impaired hepatic gluconeogenesis selectively from lactate, while significantly enhancing whole-body energy expenditure and the hepatic expression of FGF21. These metabolic changes were not a consequence of general liver dysfunction because acute SLC25A47 depletion in adult mice was sufficient to enhance hepatic FGF21 production, pyruvate tolerance, and insulin tolerance independent of liver damage and mitochondrial dysfunction. Mechanistically, SLC25A47 depletion leads to impaired hepatic pyruvate flux and malate accumulation in the mitochondria, thereby restricting hepatic gluconeogenesis. Together, the present study identified a crucial node in the liver mitochondria that regulates fasting-induced gluconeogenesis and energy homeostasis.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Glucose feeds the TCA cycle via circulating lactate

          Mammalian tissues are fuelled by circulating nutrients, including glucose, amino acids, and various intermediary metabolites. Under aerobic conditions, glucose is generally assumed to be burned fully by tissues via the tricarboxylic acid cycle (TCA cycle) to carbon dioxide. Alternatively, glucose can be catabolized anaerobically via glycolysis to lactate, which is itself also a potential nutrient for tissues and tumours. The quantitative relevance of circulating lactate or other metabolic intermediates as fuels remains unclear. Here we systematically examine the fluxes of circulating metabolites in mice, and find that lactate can be a primary source of carbon for the TCA cycle and thus of energy. Intravenous infusions of 13C-labelled nutrients reveal that, on a molar basis, the circulatory turnover flux of lactate is the highest of all metabolites and exceeds that of glucose by 1.1-fold in fed mice and 2.5-fold in fasting mice; lactate is made primarily from glucose but also from other sources. In both fed and fasted mice, 13C-lactate extensively labels TCA cycle intermediates in all tissues. Quantitative analysis reveals that during the fasted state, the contribution of glucose to tissue TCA metabolism is primarily indirect (via circulating lactate) in all tissues except the brain. In genetically engineered lung and pancreatic cancer tumours in fasted mice, the contribution of circulating lactate to TCA cycle intermediates exceeds that of glucose, with glutamine making a larger contribution than lactate in pancreatic cancer. Thus, glycolysis and the TCA cycle are uncoupled at the level of lactate, which is a primary circulating TCA substrate in most tissues and tumours.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            A single–cell type transcriptomics map of human tissues

            Single-cell RNA analysis has been integrated with spatial protein profiling to create a single–cell type map of human tissues. Advances in molecular profiling have opened up the possibility to map the expression of genes in cells, tissues, and organs in the human body. Here, we combined single-cell transcriptomics analysis with spatial antibody-based protein profiling to create a high-resolution single–cell type map of human tissues. An open access atlas has been launched to allow researchers to explore the expression of human protein-coding genes in 192 individual cell type clusters. An expression specificity classification was performed to determine the number of genes elevated in each cell type, allowing comparisons with bulk transcriptomics data. The analysis highlights distinct expression clusters corresponding to cell types sharing similar functions, both within the same organs and between organs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans.

              Pyruvate constitutes a critical branch point in cellular carbon metabolism. We have identified two proteins, Mpc1 and Mpc2, as essential for mitochondrial pyruvate transport in yeast, Drosophila, and humans. Mpc1 and Mpc2 associate to form an ~150-kilodalton complex in the inner mitochondrial membrane. Yeast and Drosophila mutants lacking MPC1 display impaired pyruvate metabolism, with an accumulation of upstream metabolites and a depletion of tricarboxylic acid cycle intermediates. Loss of yeast Mpc1 results in defective mitochondrial pyruvate uptake, and silencing of MPC1 or MPC2 in mammalian cells impairs pyruvate oxidation. A point mutation in MPC1 provides resistance to a known inhibitor of the mitochondrial pyruvate carrier. Human genetic studies of three families with children suffering from lactic acidosis and hyperpyruvatemia revealed a causal locus that mapped to MPC1, changing single amino acids that are conserved throughout eukaryotes. These data demonstrate that Mpc1 and Mpc2 form an essential part of the mitochondrial pyruvate carrier.
                Bookmark

                Author and article information

                Contributors
                Journal
                Proc Natl Acad Sci U S A
                Proc Natl Acad Sci U S A
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                22 February 2023
                28 February 2023
                22 February 2023
                : 120
                : 9
                : e2216810120
                Affiliations
                [1] aDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA 02115
                [2] bDepartment of Molecular Metabolism, Harvard T. H. Chan School of Public Health , Boston, MA 02115
                [3] cDepartment of Cell Biology, Harvard Medical School , Boston, MA 02115
                [4] dDepartment of Cancer Biology, Dana-Farber Cancer Institute , Boston, MA 02115
                [5] eHHMI , Chevy Chase, MD 20815
                Author notes
                2To whom correspondence may be addressed. Email: skajimur@ 123456bidmc.harvard.edu .

                Edited by Navdeep S. Chandel, Northwestern University, Chicago, IL; received October 3, 2022; accepted January 12, 2023 by Editorial Board Member David J. Mangelsdorf

                1J.-S.Y. and Z.H.T contributed equally to this work.

                Author information
                https://orcid.org/0000-0002-9294-6770
                https://orcid.org/0000-0003-1320-657X
                https://orcid.org/0000-0003-4207-9354
                https://orcid.org/0000-0003-0672-5910
                Article
                202216810
                10.1073/pnas.2216810120
                9992842
                36812201
                349e0d80-05e7-407c-a85d-d9abdb1c3572
                Copyright © 2023 the Author(s). Published by PNAS.

                This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY).

                History
                : 03 October 2022
                : 12 January 2023
                Page count
                Pages: 10, Words: 6894
                Funding
                Funded by: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), FundRef 100000062;
                Award ID: DP1DK126160
                Award Recipient : Pere Puigserver Award Recipient : Sheng Hui Award Recipient : Shingo Kajimura
                Funded by: Howard Hughes Medical Institute (HHMI), FundRef 100000011;
                Award ID: na
                Award Recipient : Shingo Kajimura
                Funded by: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), FundRef 100000062;
                Award ID: DK081418
                Award Recipient : Pere Puigserver Award Recipient : Sheng Hui Award Recipient : Shingo Kajimura
                Funded by: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), FundRef 100000062;
                Award ID: DK117655
                Award Recipient : Pere Puigserver Award Recipient : Sheng Hui Award Recipient : Shingo Kajimura
                Funded by: HHS | NIH | National Institute of General Medical Sciences (NIGMS), FundRef 100000057;
                Award ID: 1F32GM136019-01A1
                Award Recipient : Beste Mutlu
                Funded by: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), FundRef 100000062;
                Award ID: R00DK117066
                Award Recipient : Pere Puigserver Award Recipient : Sheng Hui Award Recipient : Shingo Kajimura
                Funded by: Paul G. Allen Family Foundation (PGAFF), FundRef 100000952;
                Award ID: 0034665
                Award Recipient : Sheng Hui
                Categories
                research-article, Research Article
                physio, Physiology
                427
                Biological Sciences
                Physiology

                bioenergetics,metabolism,obesity,type 2 diabetes,mitochondria

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content118

                Cited by7

                Most referenced authors589